ZyVersa Therapeutics's total assets for Q4 2023 were $22.11M, a decrease of -32.69% from the previous quarter. ZVSA total liabilities were $11.04M for the fiscal quarter, a -16.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.